| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |